Press Releases

Advanced Search
  • Feb 22, 2016

    Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals,...

  • Feb 17, 2016
    EMA to Review Marketing Authorization Application for Therapeutic to Treat Pain and Inflammation in Dogs with Osteoarthritis

    Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals,...

  • Jan 25, 2016
    Targeted Therapeutic Intended for Control of Pain and Inflammation in Dogs with Osteoarthritis

    Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for companion animals,...

Show 5102550100 per page